The company sees big money in leveling up its tech for screening Americans' blood, and tariffs could mean further U.S.

Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint. The medical device maker will upgrade facilities in both Illinois and Texas to expand its ...

Q1 2025 Earnings Conference Call April 16, 2025 9:00 AM ETCompany ParticipantsMike Comilla - VP, IRRobert Ford - Chairman ...

Abbott Labs boosted its earnings in the first quarter and hinted that its full-year guidance might have gotten a lift were it ...

The company plans to expand its manufacturing and R&D operations in its diagnostics transfusion business in Lake County, Illinois. Abbott Laboratories said Wednesday it will make a big investment ...

Abbott Laboratories plans to hire as many as 200 ... in Lake County are related to Abbott’s transfusion diagnostics business, which is responsible for screening the U.S. blood supply, Ford ...

ABBOTT PARK, Ill. (AP) — ABBOTT PARK, Ill. (AP) — Abbott Laboratories (ABT) on Wednesday reported first-quarter earnings of $1.33 billion. The Abbott Park, Illinois-based company said it had ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results tomorrow before the bell. Here’s what to look for. Abbott Laboratories met analysts ...

Abbott Labs ABT1.27%increase ... given the momentum they were seeing in the healthcare-products maker’s base business.